GL1X · GenesisL1 explorer

MolNFT v1 · #39527 · protein

Crystal structure of src kinase domain in complex with covalent inhibitor

2HWO · Proto-oncogene tyrosine-protein kinase src: “Crystal structure of src kinase domain in complex with covalent inhibitor”. X-ray diffraction, 1 ligand (RBS), 3 pockets (best druggability 0.74). MolNFT v1 #39527 on GenesisL1: 3D…

PDB
2HWO
Type
protein
Length
493 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase src
EC
2.7.10.2
UniProt
P00523
Ligands
RBS
Pockets
3 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein25140% helix, 16% strandP00523
BProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein24241% helix, 17% strandP00523

Ligands and binding sites

  • RBS · N-(4-phenylamino-quinazolin-6-yl)-acrylamide · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111460.740.77110RBS, GOL
22620.570.7832RBS
3550.320.7714empty

Interfaces

1 interface between chains.

  • A–B · 412 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 2HWO · Crystal structure of Src kinase domain in complex with covalent inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.